Industry

New 375mg vial addresses critical dosing gap for adult and pediatric patients living with T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma CAMBRIDGE, Mass.–(BUSINESS WIRE)–Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration has approved the company’s oncology drug, Nelarabine Injection, in a larger vial size, 375mg/75mL, … [Read more…]

Equazen® Forte represents a strategic evolution of the brand, extending its clinically researched omega-3 based cognitive support product formulation beyond children to young adults and adults through pharmacies across Poland. LUGANO, Switzerland–(BUSINESS WIRE)–#GLAsupplements–SFI Health™ EMEA, the regional entity of SFI Health™, a global leader in natural healthcare, today is pleased to announce the launch of … [Read more…]

DES PLAINES, Ill.–(BUSINESS WIRE)–United States Drug Testing Laboratories (USDTL), a national leader in forensic and clinical toxicology and mid- to long-term drug and alcohol testing, today announced a new integration partnership with CourtFact, a trusted client management platform widely used by justice-involved programs and service providers across the country. The collaboration brings USDTL’s comprehensive lab-based … [Read more…]

LAS VEGAS–(BUSINESS WIRE)–#BehavioralHealth–As the U.S. mental health system faces sustained funding instability, workforce burnout, and rising demand for rapid, nonpharmaceutical support, JOYELY, LLC, an emotional regulation pilot program, is launching in California this February. The timing reflects growing strain across the mental health ecosystem. Federal agencies and community providers have faced staffing disruptions and grant … [Read more…]

The largest autonomous healthcare conference convened 300+ leaders from over 200 organizations. SAN FRANCISCO–(BUSINESS WIRE)–Innovaccer, a leading healthcare AI company, today concluded Xccelerate 2026, its annual customer and industry conference, where healthcare executives, clinicians, policymakers, and technology leaders gathered to address a growing challenge facing the industry: how to meet rising demand for care with … [Read more…]

Gift sparks curriculum transformation, new lectureship, and names Entrepreneurship Pathway in honor of alumnus Rod Wong, M’03 PHILADELPHIA–(BUSINESS WIRE)–A landmark $8 million gift from the RTW Foundation, led by Penn Medicine Board of Trustees member Rod Wong, M’03, and Marti Speranza Wong, C’98, will launch a bold initiative to reimagine medical education at the Perelman … [Read more…]

AI-powered workflows embedded in the WellSky Enterprise Referral Manager solution help home health and hospice providers address intake complexity and staffing constraints OVERLAND PARK, Kan.–(BUSINESS WIRE)–Today, WellSky announced new AI-powered referral management workflows aimed at helping home health and hospice providers centralize intake, manage referral complexity, and efficiently process growing volumes of patient referrals, as … [Read more…]

NEW YORK–(BUSINESS WIRE)–People who need complex spine surgery have a new option for state-of-the-art, comprehensive spine care. The Complex Spine & Scoliosis Center (CSSC) at Hospital for Special Surgery (HSS) is designed to give patients an easier recovery and a better overall experience thanks to its team of expert physicians dedicated to treating complex spine … [Read more…]

NASHVILLE, Tenn.–(BUSINESS WIRE)–HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the fourth quarter ended December 31, 2025. Key fourth quarter metrics (all percentage changes compare 4Q 2025 to 4Q 2024 unless otherwise noted): Revenues increased 6.7 percent to $19.513 billion Net income attributable to HCA Healthcare, Inc. increased 30.6 percent to … [Read more…]

– A once-weekly subcutaneous injection of CT-388 achieved a statistically significant placebo-adjusted weight loss of 22.5% (p < 0.001) at 48 weeks at the highest dose tested (24 mg), without reaching a weight loss plateau – – 54% of participants on the 24 mg dose achieved resolution of obesity (BMI <30 kg/m2) vs. 13% in … [Read more…]